Red Light Therapy During Pregnancy: What You Need to Know
Pregnancy brings joy, anticipation, and—for many women—physical discomfort. Back pain, pelvic pain, and muscle tension are common during pregnancy, and the need for safe pain relief becomes urgent. Red light therapy offers a non-pharmaceutical option, but using any new therapy during pregnancy requires careful consideration. This guide reviews the current evidence, explains what we know and don't know about photobiomodulation during pregnancy, and provides guidance for conversations with your healthcare provider.
What the Research Currently Shows
Clinical research specifically examining red light therapy during pregnancy is extremely limited. This doesn't mean the therapy is unsafe—it means human studies haven't been conducted at scale. What we do know comes from safety profiles in non-pregnant populations and a small number of case reports.
A 2017 review in the Journal of Obstetrics and Gynaecology examined low-level laser therapy during pregnancy and found that no adverse effects were reported in limited case studies, though more research is needed.
A comprehensive 2017 review published in Seminars in Cutaneous Medicine and Surgery examined the photobiomodulation safety profile and noted that LLLT has a favorable safety profile, though pregnancy is listed as a relative contraindication pending further research.
The key insight: Photobiomodulation is non-thermal and non-ionizing, which means it doesn't generate excessive heat or harmful radiation. However, the precautionary principle suggests waiting for more direct evidence before using it during pregnancy, especially in the first trimester.
Considerations by Trimester
Chris Bohler The first trimester is when major fetal organ systems develop. This is the most critical period for avoiding any potential risks. Most practitioners recommend avoiding red light therapy during this time, even though no adverse effects have been reported. If you are experiencing severe pain and considering RLT, discuss it explicitly with your OB-GYN.
Second Trimester (Weeks 14–20): By the second trimester, major organ development is complete. Some women, with their doctor's approval, use red light therapy for back pain and joint discomfort during this period. If your healthcare provider gives the go-ahead, treatment can begin—but always avoid direct abdominal application and limit frequency to 2–3 sessions per week.
Third Trimester (Weeks 21–40): The third trimester poses different challenges, including increased back pain, pelvic pressure, and circulation issues. Red light therapy may help manage these symptoms, particularly for localized pain. Again, with physician approval and careful attention to avoiding the abdomen, RLT can be used. Many women find relief from lower back and hip pain during this final stretch.
The critical message: Never use red light therapy without explicit clearance from your OB-GYN, regardless of trimester.
Safe Use Guidelines for Pregnant Women
Before starting treatment:
- Schedule an appointment with your OB-GYN and discuss photobiomodulation therapy specifically.
- Bring information about the MOVE+, including wavelength (808nm), power output, and intended use.
- Disclose any pregnancy complications, previous miscarriages, or high-risk factors.
- Ask directly: "Is red light therapy safe for me and my pregnancy?"
If your doctor approves:
- Wait until at least week 13 (end of first trimester) before starting treatment.
- Begin with lower frequency—2 times per week—and observe for any changes in symptoms or discomfort.
- Never apply the device directly to the abdomen or over the uterus.
- Limit each treatment to 10–15 minutes.
- Focus on areas like the lower back, hips, shoulders, and neck for pain relief.
- Stop immediately if you experience unusual symptoms: spotting, cramping, dizziness, or nausea that is unrelated to normal pregnancy symptoms.
Documentation and communication:
- Keep records of your treatments (date, area treated, duration, any changes in symptoms).
- Report your use of RLT to all healthcare providers involved in your pregnancy care.
- Attend all scheduled prenatal appointments and report any concerns immediately.
When to Consult Your Healthcare Provider
Contact your OB-GYN before starting red light therapy if you have:
- History of miscarriage or pregnancy loss
- Placental abnormalities or preeclampsia risk
- Gestational diabetes or other pregnancy-related conditions
- Intrauterine growth restrictions (IUGR) or other fetal concerns
- Cerclage or other surgical interventions during pregnancy
- Preterm labor risk factors
- Any condition listed as high-risk by your care team
Stop red light therapy immediately and contact your healthcare provider if you experience:
- Vaginal spotting or bleeding
- Cramping or abdominal pain unrelated to Braxton-Hicks contractions
- Dizziness, fainting, or vision changes
- Shortness of breath or chest pain
- Fever or signs of infection
- Sudden reduction in fetal movement (third trimester)
Frequently Asked Questions
⚠️ Safety Considerations for Pregnancy
- First trimester: Avoid until more research is available.
- Avoid direct abdominal application: Never apply the device over the uterus or abdomen during any trimester.
- Consult OB-GYN before use: Get explicit approval from your obstetrician before starting any red light therapy.
- Do not use if pregnancy is high-risk: If you have preeclampsia risk, preterm labor concerns, or other complications, consult your doctor first.
- Always follow device manufacturer guidelines: Use the MOVE+ according to instructions, and never exceed recommended treatment duration.
Related Reading
Effective Pain Relief, Carefully Considered
During pregnancy, safety is paramount. The MOVE+ offers a non-pharmaceutical option for pain management—when approved by your healthcare provider. Thousands of women trust Kineon for clinical-grade light therapy tailored to their needs.
Explore MOVE+